| Name | Bosutinib (SKI-606) | CAS# | 380843-75-4 | |
|---|---|---|---|---|
| Price | ¥Inquiry/1g | Purity | 98.9% | |
| Stocking Period |
1 Day | Stock | In Stock |
| Detail
Product Information
Bosutinib is a synthetic quinolone derivative and dual kinase inhibitor that targets both Abl and Src kinases with potential antineoplastic activity. |
Get all suppliers by the below link:
| 2024-07-15 |
Bosutinib (SKI-606)
Price: Inquiry |
| 2020-01-06 |
Bosutinib (SKI-606)
Price: $100.0 |
| 2025-09-17 |
Bosutinib (SKI-606)
Price: ¥Inquiry |
| 2024-01-09 |
380843-75-4 Bosutinib
Price: $Inquiry |
| 2017-06-12 |
Bosutinib (SKI-606)
Price: ¥Inquiry |
| 2018-01-31 |
Bosutinib (SKI-606)
Price: ¥365.0 |
| 2017-11-09 |
Bosutinib (SKI-606)
Price: ¥Inquiry |
| 2017-07-05 |
Bosutinib (SKI-606)
Price: ¥Inquiry |
| 2021-05-10 |
Bosutinib (SKI-606)
Price: ¥Inquiry |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved


